JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB258404

Human EEF1E1 (AIMP3/p18) knockout HEK-293T cell lysate

Be the first to review this product! Submit a review

|

(0 Publication)

EEF1E1 KO cell lysate available now. KO validated. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 1.
1 Images
Sanger Sequencing - Human EEF1E1 (AIMP3/p18) knockout HEK-293T cell lysate (AB258404)
  • Sanger seq

Unknown

Sanger Sequencing - Human EEF1E1 (AIMP3/p18) knockout HEK-293T cell lysate (AB258404)

Homozygous : Insertion of the selection cassette in exon 1

Key facts

Cell type

HEK-293T

Species or organism

Human

Tissue

Kidney

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: Insertion of the selection cassette in exon 1.

Product details

Knockout cell lysate achieved by CRISPR/Cas9.

REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1Kit": { "sellingSize": "1 Kit", "publicAssetCode":"ab258404-1Kit", "assetComponentDetails": [ { "size":"1 x 100 µg", "name":"Human EEF1E1 knockout HEK293T cell lysate", "number":"AB258404-CMP01", "productcode":"" }, { "size":"1 x 100 µg", "name":"Human wild-type HEK293T cell lysate", "number":"AB258404-CMP02", "productcode":"" } ] } } }

Properties and storage information

Gene name
EEF1E1
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

AIMP3 also known as p18 or eEF1A1 is a protein that plays an important role in cellular processes. It has a molecular mass of approximately 18 kDa. AIMP3 is expressed ubiquitously meaning it can be found in a variety of tissues throughout the body. As a part of the aminoacyl-tRNA synthetase (ARS) complex AIMP3 contributes to protein translation assisting in the assembly of necessary components for peptide chain formation.
Biological function summary

The role of AIMP3 extends beyond its contribution to protein synthesis. This protein participates in the macromolecular ARS complex which is essential for accurate and efficient translation of the genetic code into functional proteins. AIMP3 acts as a scaffold stabilizing the assembly and function of the ARS complex. Its involvement is critical for maintaining the fidelity of protein synthesis as errors in this process can lead to cellular dysfunction.

Pathways

AIMP3 engages in several key biological processes. It functions within the DNA damage response pathway where it interacts with proteins such as ATM and ATR to facilitate DNA repair mechanisms. Additionally AIMP3 is involved in the p53 signaling pathway where it contributes to the regulation of cell cycle and apoptosis. This interaction highlights the protein's role in maintaining genomic stability and preventing tumorigenesis.

AIMP3 has implications in cancer and neurodegenerative diseases. In cancer downregulation or mutations in AIMP3 can disrupt the DNA repair process leading to genomic instability and tumor development. The protein's interaction with p53 is particularly important as p53 mutations are common in a variety of cancers. Additionally AIMP3 has been associated with neurodegenerative disorders where improper protein synthesis may contribute to disease progression. Its relationship with these conditions highlights the broad impact of AIMP3 on human health.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com